Not yet recruiting
Paroxysmal nocturnal haemoglobinuria
Not yet recruitingStudy of VSA012 Sodium in Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Complement Inhibitor‑Naïve or Have Persistent Anemia on C5 Inhibitor Therapy
InvestigationalNo placebo
Study of VSA012 Sodium in Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Complement Inhibitor‑Naïve or Have Persistent Anemia on C5 Inhibitor Therapy
InvestigationalNo placebo
- Disease:Paroxysmal nocturnal haemoglobinuria
- Substances:–
Countries:
France
France- Participants:18–64 years · 65+ years
- Sponsor:Bisirna Therapeutics Pte. Ltd.



